May 31, 2017 / 12:48 PM / 2 months ago

BRIEF-Evoke Pharma enters agreement with Rho to submit NDA for Gimoti

1 Min Read

May 31 (Reuters) - Evoke Pharma Inc

* Evoke Pharma enters agreement with Rho to submit NDA for Gimoti

* Evoke Pharma Inc - entered into agreement with Rho Inc for submission of its planned new drug application for Gimoti

* Evoke Pharma says remain on track to initiate and complete our PK study in second half of this year with our NDA submission by late 2017 or early 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below